Detalhe da pesquisa
1.
Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
J Neural Transm (Vienna)
; 127(2): 189-203, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31912279
2.
Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.
Haematologica
; 101(1): 38-45, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26385212
3.
Iron as a therapeutic target for Parkinson's disease.
Mov Disord
; 33(4): 568-574, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29380903
4.
The role of endocytic pathways in cellular uptake of plasma non-transferrin iron.
Haematologica
; 97(5): 670-8, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22180428
5.
Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.
Am J Hematol
; 87(1): 55-61, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22125177
6.
Transferrin-iron routing to the cytosol and mitochondria as studied by live and real-time fluorescence.
Biochem J
; 429(1): 185-93, 2010 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20408812
7.
Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation.
Blood
; 112(13): 5219-27, 2008 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18796625
8.
Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation.
Can J Physiol Pharmacol
; 88(3): 187-96, 2010 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-20393584
9.
Intracellular labile iron.
Int J Biochem Cell Biol
; 40(3): 350-4, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-17451993
10.
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
Antioxid Redox Signal
; 29(8): 742-748, 2018 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29287521
11.
Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women.
Circulation
; 113(16): 1942-9, 2006 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-16618820
12.
LPI-labile plasma iron in iron overload.
Best Pract Res Clin Haematol
; 18(2): 277-87, 2005 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-15737890
13.
Objectives and mechanism of iron chelation therapy.
Ann N Y Acad Sci
; 1054: 124-35, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16339658
14.
Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?
Ann N Y Acad Sci
; 1054: 118-23, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16339657
15.
Iron chelation therapy.
Curr Hematol Rep
; 4(2): 110-6, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15720959
16.
The labile iron pool: characterization, measurement, and participation in cellular processes(1).
Free Radic Biol Med
; 33(8): 1037-46, 2002 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12374615
17.
Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade.
PLoS One
; 9(11): e112915, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25390893
18.
Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
Antioxid Redox Signal
; 21(2): 195-210, 2014 Jul 10.
Artigo
Inglês
| MEDLINE | ID: mdl-24251381
19.
Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal.
Br J Pharmacol
; 164(2b): 406-18, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21091647
20.
Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes.
Leuk Res
; 34(12): 1560-5, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20615548